• Increased earnings and dividends in FY25
• Acquisitions in Canada drive improved financial performance
• Organic revenue growth in ANZ despite lower international filings

IPH Ltd reported strong financial results for the 2025 financial year, with increased earnings and dividends. The company's underlying EBITDA grew by 6% to $207.2 million, while underlying NPATA increased by 7% to $120.6 million. The company's revenue, including other income, grew by 16.5% to $710.3 million, largely driven by acquisitions in the Canadian segment. The company saw organic revenue growth in Australia and New Zealand, despite a decline in the overall patent market, as IPH maintained its market share among higher-value international filers. The company's acquisitions in Canada, including the integration of Bereskin & Parr, also contributed to the improved financial performance. IPH continued to generate strong cash flow, with a 103% conversion of EBITDA to gross operating cash flow. The company also restructured its corporate services and executive leadership team to better support growth and risk management across its member firms. Looking ahead, IPH is focused on optimizing operations, embedding AI into core processes, and leveraging anticipated revenue recovery as CIPO issues are resolved in Canada.

IPH expects to achieve annualized cost savings of $8 million to $10 million from FY26 onwards through its operational optimization efforts.

IPH is focused on driving operational efficiencies to leverage its scale and capabilities across the group, as well as optimizing its corporate structure to better support growth and risk management at the member firm level. The company is also investing in technology, including the integration of AI, to streamline workflows and reduce costs.